Harvard Bioscience, Inc.
HBIO
$5.37
-$0.18-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.69% | 49.20% | 83.84% | 30.34% | -4.09% |
| Total Receivables | 7.92% | -5.63% | -4.40% | -11.95% | -7.66% |
| Inventory | -10.50% | -16.88% | -11.44% | -5.47% | -5.95% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.66% | -3.70% | -30.03% | -31.18% | -26.45% |
| Total Current Assets | 6.89% | -6.38% | -3.15% | -6.74% | -8.00% |
|
|
|||||
| Total Current Assets | 6.89% | -6.38% | -3.15% | -6.74% | -8.00% |
| Net Property, Plant & Equipment | 6.42% | 6.35% | 31.23% | 38.88% | 28.38% |
| Long-term Investments | -83.03% | -83.42% | -82.07% | -84.20% | -1.30% |
| Goodwill | -83.03% | -83.42% | -82.07% | -84.20% | -1.30% |
| Total Other Intangibles | -31.38% | -32.10% | -32.01% | -30.99% | -30.58% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.08% | 29.72% | 18.33% | 14.00% | -4.71% |
| Total Assets | -36.77% | -40.57% | -37.87% | -40.07% | -7.81% |
|
|
|||||
| Total Accounts Payable | -23.71% | -2.03% | -17.32% | -20.45% | -13.81% |
| Total Accrued Expenses | 57.46% | -14.43% | 2.65% | -29.18% | -48.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -96.00% | 649.06% | 660.09% | 660.16% | 423.90% |
| Total Finance Division Other Current Liabilities | 34.99% | 14.25% | 20.88% | -1.91% | 5.53% |
| Total Other Current Liabilities | 34.99% | 14.25% | 20.88% | -1.91% | 5.53% |
| Total Current Liabilities | -60.04% | 139.09% | 144.03% | 116.55% | 107.06% |
|
|
|||||
| Total Current Liabilities | -60.04% | 139.09% | 144.03% | 116.55% | 107.06% |
| Long-Term Debt | 36,132.32% | -- | -99.86% | -- | -99.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.85% | 9.33% | 48.46% | 58.66% | 33.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.92% | 10.63% | -10.71% | -4.13% | -9.11% |
| Total Liabilities | 4.79% | -3.02% | 4.37% | 0.96% | -1.54% |
|
|
|||||
| Common Stock & APIC | 1.31% | 0.83% | 1.16% | 1.57% | 1.78% |
| Retained Earnings | -35.88% | -34.07% | -37.46% | -38.62% | -8.52% |
| Treasury Stock & Other | 25.51% | 4.76% | 21.29% | 2.80% | -10.43% |
| Total Common Equity | -78.32% | -78.46% | -76.60% | -78.44% | -13.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -78.32% | -78.46% | -76.60% | -78.44% | -13.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -78.32% | -78.46% | -76.60% | -78.44% | -13.32% |
|
|
|||||